IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Enanta Pharmaceuticals, Inc.

CUSIP: 029251M10 | 1 institutional holders

Quarters

Q2 2016
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2016

Stonepine Capital Management, LLC52,616
1.2% of portfolio›$1.2K
StyleTurnoverLocationFiled
Stonepine Capital Management, LLC
52,616$1.2K1.2%Deep ValueHighBend, OR2016-08-11